Literature DB >> 27381400

The DNA Polymerase Gamma R953C Mutant Is Associated with Antiretroviral Therapy-Induced Mitochondrial Toxicity.

Min Li1, Andrea C Mislak2, Yram Foli1, Esinam Agbosu1, Vivek Bose1, Shreya Bhandari1, Michal R Szymanski3, Christie K Shumate3, Y Whitney Yin4, Karen S Anderson5, Elijah Paintsil6.   

Abstract

We found a heterozygous C2857T mutation (R953C) in polymerase gamma (Pol-γ) in an HIV-infected patient with mitochondrial toxicity. The R953C Pol-γ mutant binding affinity for dCTP is 8-fold less than that of the wild type. The R953C mutant shows a 4-fold decrease in discrimination of analog nucleotides relative to the wild type. R953 is located on the "O-helix" that forms the substrate deoxynucleoside triphosphate (dNTP) binding site; the interactions of R953 with E1056 and Y986 may stabilize the O-helix and affect polymerase activity.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27381400      PMCID: PMC4997837          DOI: 10.1128/AAC.00976-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Parkinsonism, premature menopause, and mitochondrial DNA polymerase gamma mutations: clinical and molecular genetic study.

Authors:  Petri Luoma; Atle Melberg; Juha O Rinne; Jyrki A Kaukonen; Nina N Nupponen; Richard M Chalmers; Anders Oldfors; Ilkka Rautakorpi; Leena Peltonen; Kari Majamaa; Hannu Somer; Anu Suomalainen
Journal:  Lancet       Date:  2004 Sep 4-10       Impact factor: 79.321

2.  Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.

Authors:  Rita Horvath; Gavin Hudson; Gianfrancesco Ferrari; Nancy Fütterer; Sofia Ahola; Eleonora Lamantea; Holger Prokisch; Hanns Lochmüller; Robert McFarland; V Ramesh; Thomas Klopstock; Peter Freisinger; Fabrizio Salvi; Johannes A Mayr; Rene Santer; Marketa Tesarova; Jiri Zeman; Bjarne Udd; Robert W Taylor; Douglass Turnbull; Michael Hanna; Doreen Fialho; Anu Suomalainen; Massimo Zeviani; Patrick F Chinnery
Journal:  Brain       Date:  2006-04-18       Impact factor: 13.501

3.  Mitochondrial DNA polymerase gamma mutations: an ever expanding molecular and clinical spectrum.

Authors:  Sha Tang; Jing Wang; Ni-Chung Lee; Margherita Milone; Michelle C Halberg; Eric S Schmitt; William J Craigen; Wei Zhang; Lee-Jun C Wong
Journal:  J Med Genet       Date:  2011-08-31       Impact factor: 6.318

Review 4.  Pharmacology of nucleoside and nucleotide reverse transcriptase inhibitor-induced mitochondrial toxicity.

Authors:  T N Kakuda
Journal:  Clin Ther       Date:  2000-06       Impact factor: 3.393

5.  Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)-like phenotype: an expanded clinical spectrum of POLG1 mutations.

Authors:  Sha Tang; Elliot L Dimberg; Margherita Milone; Lee-Jun C Wong
Journal:  J Neurol       Date:  2011-10-13       Impact factor: 4.849

6.  Relationship between polymerase gamma (POLG) polymorphisms and antiretroviral therapy-induced lipodystrophy in HIV-1 infected patients: a case-control study.

Authors:  Franck Chiappini; Elina Teicher; Raphaël Saffroy; Brigitte Debuire; Daniel Vittecoq; Antoinette Lemoine
Journal:  Curr HIV Res       Date:  2009-03       Impact factor: 1.581

7.  Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors.

Authors:  Graeme J Moyle; Debasis Datta; Sundhiya Mandalia; John Morlese; David Asboe; Brian G Gazzard
Journal:  AIDS       Date:  2002-07-05       Impact factor: 4.177

8.  Mutations in human DNA polymerase γ confer unique mechanisms of catalytic deficiency that mirror the disease severity in mitochondrial disorder patients.

Authors:  Christal D Sohl; Rajesh Kasiviswanathan; William C Copeland; Karen S Anderson
Journal:  Hum Mol Genet       Date:  2012-12-03       Impact factor: 6.150

9.  Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs.

Authors:  Susan E Lim; Mikhail V Ponamarev; Matthew J Longley; William C Copeland
Journal:  J Mol Biol       Date:  2003-05-23       Impact factor: 5.469

10.  Increased mtDNA levels without change in mitochondrial enzymes in peripheral blood mononuclear cells of infants born to HIV-infected mothers on antiretroviral therapy.

Authors:  Grace A McComsey; Minhee Kang; Allison C Ross; Dirk Lebrecht; Elizabeth Livingston; Ann Melvin; Jane Hitti; Susan E Cohn; Ulrich A Walker
Journal:  HIV Clin Trials       Date:  2008 Mar-Apr
View more
  4 in total

Review 1.  A Critical Review of the Biochemical Mechanisms and Epigenetic Modifications in HIV- and Antiretroviral-Induced Metabolic Syndrome.

Authors:  Jivanka Mohan; Terisha Ghazi; Anil A Chuturgoon
Journal:  Int J Mol Sci       Date:  2021-11-06       Impact factor: 5.923

Review 2.  Off-Target Effects of Drugs that Disrupt Human Mitochondrial DNA Maintenance.

Authors:  Matthew J Young
Journal:  Front Mol Biosci       Date:  2017-11-22

3.  Identifying the role of PrimPol in TDF-induced toxicity and implications of its loss of function mutation in an HIV+ patient.

Authors:  Vincent N Duong; Lei Zhou; María I Martínez-Jiménez; Linh He; Moises Cosme; Luis Blanco; Elijah Paintsil; Karen S Anderson
Journal:  Sci Rep       Date:  2020-06-09       Impact factor: 4.379

Review 4.  Mitochondria as the Target of Hepatotoxicity and Drug-Induced Liver Injury: Molecular Mechanisms and Detection Methods.

Authors:  Milos Mihajlovic; Mathieu Vinken
Journal:  Int J Mol Sci       Date:  2022-03-18       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.